Fulgent Genetics (FLGT) EBITDA (2015 - 2026)
Fulgent Genetics (FLGT) EBITDA from Sep 30, 2015 to Mar 31, 2026. The TTM Fulgent Genetics (FLGT) EBITDA is -$82M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Fulgent Genetics (FLGT) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +71.19% |
| 3 Years TTM | +82.78% |
Annual EBITDA change of Fulgent Genetics (FLGT)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$29M | -57.26% |
| 2025 | -$67M | +36.70% |
| 2024 | -$49M | -71.08% |
| 2023 | -$169M | -180.21% |
| 2022 | $211M | -69.26% |
| 2021 | $687M | +134.36% |
| 2020 | $293M | +17347.62% |
| 2019 | $1.68M | -157.73% |
| 2018 | -$2.91M | +66.29% |
| 2017 | -$1.75M | -183.73% |
| 2016 | $2.09M | -147.07% |
| 2015 | -$4.44M | +462.03% |
| 2014 | -$790K | N/A |